Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIPARP antisense RNA 1 (TIPARP-AS1), also known as LINC00886, is a long non-coding RNA (lncRNA) gene located at 3q25.31 on chromosome 3[2][3][4]. It is classified as an lncRNA and does not code for a protein. TIPARP-AS1 is transcribed antisense to the TIPARP (TCDD Inducible Poly(ADP-Ribose) Polymerase) gene. Its specific biological function has not been characterized in detail, and it is not recognized as a protein-coding target, receptor, enzyme, transporter, or established therapeutic target[2][3][4]. Some databases list it among genes associated with disease, but there are currently no approved drugs or specific therapeutic mechanisms of action targeting TIPARP-AS1, nor is it used as a biomarker in clinical practice. Clarifications based on guidelines: - TIPARP-AS1 / LINC00886 is not a therapeutic target (not a receptor, enzyme, transporter, etc.) and is best classified as a long non-coding RNA[3][4]. - No known interacting drugs, mechanisms of action, or prominent disease roles are established to date[3][4]. - No apparent incorrectness in target naming, but not a classic druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TIPARP antisense RNA 1 (TIPARP-AS1).